ALNYLAM PHARMACEUTICALS INC

CUSIP: 02043QAB3 Class: NOTE 1.000% 9/1

RWC Asset Management LLP's Holding History (CIK: 0001520478)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025
Shares 2,700,000 Value ($000) $3,482 Avg Close — Range —
Q1 2025
Shares 4,100,000 Value ($000) $4,735 Avg Close — Range —
Q4 2024
Shares 4,100,000 Value ($000) $4,382 Avg Close — Range —
Q3 2024
Shares 4,100,000 Value ($000) $4,796 Avg Close — Range —
Q2 2024
Shares 4,600,000 Value ($000) $4,960 Avg Close — Range —
Q1 2024
Shares 4,200,000 Value ($000) $3,959 Avg Close — Range —
Q4 2023
Shares 3,200,000 Value ($000) $3,160 Avg Close — Range —
Q3 2023
Shares 3,200,000 Value ($000) $2,972 Avg Close — Range —